Sector revisions Cybin Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2026-06-05 pm EDT			5-day change	1st Jan Change
4.150 ^USD	-6.32%		-8.79%	-49.27%

Apr. 30	Cybin Inc. will Change its Name to Helus Pharma	CI
Apr. 28	Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. Revenue rev.	1y. Revenue rev.	Visibility	Nbr of analysts
CYBIN INC.	-	-	-		8
ARGENX SE					15
WUXI APPTEC CO., LTD.					16
BIONTECH SE					19
INSMED INCORPORATED					21
WUXI BIOLOGICS (CAYMAN) INC.					22
GENMAB A/S					15
EXELIXIS, INC.					17
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.					17
SUMMIT THERAPEUTICS INC.					13
MADRIGAL PHARMACEUTICALS, INC.					14
PHARMAESSENTIA CORPORATION					6
AKESO, INC.					21
ARROWHEAD PHARMACEUTICALS, INC.					12
CYTOKINETICS, INCORPORATED					20
IMMUNITYBIO, INC.					3
NUVALENT, INC.					19
REMEGEN CO., LTD.					15
SAMSUNG EPIS HOLDINGS CO., LTD.				-	1
BIOCON LIMITED					20
Average					15
Weighted average by Cap.					16